Macromolecular permeability across the blood-nerve and blood-brain barriers.

No abstract is available for this paper.

• Publication year

  1994

• Venue

  Proceedings of the National Academy of Sciences of the United States of America

• Publication date

  1994-06-07

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1073/PNAS.91.12.5705PMID 8202551PMCID PMC44065
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Transcytosis of macromolecules through the blood-brain barrier: a cell biological perspective and critical appraisal

  2004cited by this paper
• The mouse blood-brain barrier and blood-nerve barrier for IgG: A tracer study by use of the avidin-biotin system

  2004cited by this paper
• Nerve growth factor receptor immunoreactivity in human benign peripheral nerve sheath tumor

  2004cited by this paper
• Receptor-mediated endocytosis of transferrin at the blood-brain barrier.

  1993cited by this paper
• Peptidases, Peptides, and the Mammalian Blood–Brain Barrier

  1993cited by this paper
• Transcytosis of protein through the mammalian cerebral epithelium and endothelium. II. Adsorptive transcytosis of WGA-HRP and the blood-brain and brain-blood barriers

  1993cited by this paper
• Drug transport across the blood-brain barrier

  1993cited by this paper
• Insulin in the brain: a hormonal regulator of energy balance.

  1992cited by this paper
• Iron and transferrin uptake by brain and cerebrospinal fluid in the rat.

  1992cited by this paper
• Permeability of the blood-brain barrier to peptides: an approach to the development of therapeutically useful analogs.

  1992cited by this paper
• Saturable transport of manganese(II) across blood-nerve barrier of rat peripheral nerve.

  1992cited by this paper
• Drug transport across the blood — brain barrier

  1992cited by this paper
• Nerve growth factor receptor immunoreactivity in non-nervous structures of the adult rat brain.

  1992cited by this paper
• Transendothelial transport of serum albumin: a quantitative immunocytochemical study

  1992cited by this paper
• Increased permeability across the blood-nerve barrier of albumin glycated in vitro and in vivo from patients with diabetic polyneuropathy.

  1992cited by this paper
• The mechanism of action of nerve growth factor.

  1991cited by this paper
• Anti-transferrin receptor antibody and antibody-drug conjugates cross the blood-brain barrier.

  1991cited by this paper
• Recycling kinetics and transcytosis of transferrin in primary cultures of bovine brain microvessel endothelial cells

  1991cited by this paper
• Chronic nerve growth factor treatment of normotensive rats.

  1991cited by this paper
• Ultrastructural study of transcellular transport of native and cationized albumin in cultured goat brain microvascular endothelium [corrected].

  1991cited by this paper
• Selective transport of an anti-transferrin receptor antibody through the blood-brain barrier in vivo.

  1991cited by this paper
• Insulin receptors in the central nervous system: localization, signalling mechanisms and functional aspects.

  1991cited by this paper
• Delivering Peptides to the Central Nervous System: Dilemmas and Strategies

  1991cited by this paper
• Regional blood-brain barrier transport of cationized bovine serum albumin in awake rats.

  1991cited by this paper
• Are genetically hypertensive rats deficient in nerve growth factor?

  1991cited by this paper
• New role of nerve growth factor--an inhibitory neuromodulator of adrenergic transmission.

  1991cited by this paper
• Recombinant human nerve growth factor is biologically active and labels novel high-affinity binding sites in rat brain.

  1991cited by this paper
• Ultrastructural study of transcellular transport of native and cationized albumin in cultured sheep brain microvascular endothelium

  1991cited by this paper
• A saturable mechanism for transport of immunoglobulin G across the blood-brain barrier of the guinea pig.

  1990cited by this paper
• Distribution of nerve growth factor receptor-like immunoreactivity in the adult rat central nervous system. Effect of colchicine and correlation with the cholinergic system--I. Forebrain.

  1990cited by this paper
• Nerve growth factor receptor-like immunoreactivity in nerve fibers in the spinal and medullary dorsal horn of the adult monkey and cat: correlation with calcitonin gene-related peptide-like immunoreactivity.

  1990cited by this paper
• Distribution of nerve growth factor receptor-like immunoreactivity in the adult rat central nervous system. Effect of colchicine and correlation with the cholinergic system--II. Brainstem, cerebellum and spinal cord.

  1990cited by this paper
• Stereospecific transport of Tyr-MIF-1 across the blood-brain barrier by peptide transport system-1.

  1990cited by this paper
• Localization of nerve growth factor receptor messenger RNA and protein in the adult rat brain.

  1989cited by this paper
• Immunohistochemical localization and biochemical characterization of nerve growth factor receptor in adult rat brain

  1989cited by this paper
• Blood-nerve transfer of albumin and its implications for the endoneurial microenvironment.

  1989cited by this paper
• Nerve growth factor receptor is associated with cholinergic neurons of the basal forebrain but not the pontomesencephalon.

  1989cited by this paper
• Transport of histone through the blood-brain barrier.

  1989cited by this paper
• Permeability and Mechanism of Albumin, Cationized Albumin, and Glycosylated Albumin Transcellular Transport Across Monolayers of Cultured Bovine Brain Capillary Endothelial Cells

  1989cited by this paper
• Implications of the Blood-Brain Barrier and Its Manipulation

  1989cited by this paper
• Blood-brain barrier transport of cationized immunoglobulin G: enhanced delivery compared to native protein.

  1989cited by this paper
• Differential effect of aluminum on the blood-brain barrier transport of peptides, technetium and albumin.

  1988cited by this paper
• An immunohistochemical study of the nerve growth factor receptor in developing rats

  1988cited by this paper
• Expression of nerve growth factor receptor in paraffin-embedded soft tissue tumors.

  1988cited by this paper
• Increase in albumin, IgG, and IgM blood-nerve barrier indices in human diabetic neuropathy.

  1988cited by this paper
• Expression of nerve growth factor receptors by Schwann cells of axotomized peripheral nerves: ultrastructural location, suppression by axonal contact, and binding properties

  1988cited by this paper
• Localization of high-affinity and low-affinity nerve growth factor receptors in cultured rat basal forebrain.

  1988cited by this paper
• Vascular transport of insulin to rat cardiac muscle. Central role of the capillary endothelium.

  1988cited by this paper
• Characterization of specific receptors for atrial natriuretic factor on cultured bovine brain capillary endothelial cells.

  1988cited by this paper
• Nerve growth factor receptors in the central nervous system.

  1988cited by this paper
• Transcytosis of albumin in capillary endothelium

  1987cited by this paper
• Absorptive-mediated endocytosis of cationized albumin and a beta-endorphin-cationized albumin chimeric peptide by isolated brain capillaries. Model system of blood-brain barrier transport.

  1987cited by this paper
• Specific binding of atrial natriuretic factor in brain microvessels.

  1987cited by this paper
• Carrier‐mediated transport of vasorpressin across the blood‐brain barrier of the mouse

  1987cited by this paper
• D-[Ala1]-peptide T-amide is transported from blood to brain by a saturable system.

  1987cited by this paper
• Human blood-brain barrier transferrin receptor.

  1987cited by this paper
• Demonstration and structural comparison of receptors for insulin-like growth factor-I and -II (IGF-I and -II) in brain and blood-brain barrier.

  1987cited by this paper
• Blood-brain barrier transcytosis of insulin in developing rabbits.

  1987cited by this paper
• Chimeric peptides as a vehicle for peptide pharmaceutical delivery through the blood-brain barrier.

  1987cited by this paper
• Receptor‐mediated transcytosis of transferrin across the blood‐brain barrier

  1987cited by this paper
• Binding and Internalization of Insulin and Insulin-Like Growth Factors by Isolated Brain Microvessels

  1986cited by this paper
• Specific binding sites for albumin restricted to plasmalemmal vesicles of continuous capillary endothelium: receptor-mediated transcytosis

  1986cited by this paper
• Absence of albumin receptor on brain capillaries in vivo or in vitro.

  1985cited by this paper
• Mammalian endoneurial fluid: collection and protein analysis from normal and crushed nerves.

  1985cited by this paper
• Human Blood—Brain Barrier Insulin Receptor

  1985cited by this paper
• In-vivo endocytosis by bristle-coated pits and intracellular transport of endogenous albumin in the endothelium of the sinuses of liver and bone marrow

  1985cited by this paper
• MIF-1 antagonizes warm-, but not cold-water stress-induced analgesia: dissociation from immobility.

  1985cited by this paper
• Measurement of protein using bicinchoninic acid.

  1985cited by this paper
• Receptor-mediated transport of insulin across endothelial cells.

  1985cited by this paper
• Endocytosis of formaldehyde-denatured serum albumin by nonparenchymal liver cells in vitro.

  1984cited by this paper
• A brain-to-blood carrier-mediated transport system for small, N-tyrosinated peptides.

  1984cited by this paper
• Transferrin receptor on endothelium of brain capillaries

  1984cited by this paper
• Graphical Evaluation of Blood-to-Brain Transfer Constants from Multiple-Time Uptake Data

  1983cited by this paper
• Hepatic uptake of albumin-bound substances: albumin receptor concept.

  1983cited by this paper
• Studies of albumin binding to rat liver plasma membranes. Implications for the albumin receptor hypothesis.

  1983cited by this paper
• Altered blood-nerve barrier in experimental lead neuropathy assessed by changes in endoneurial albumin concentration

  1982cited by this paper
• Albumin helps mediate removal of taurocholate by rat liver.

  1981cited by this paper
• Differentiated microdomains on the luminal surface of the capillary endothelium. I. Preferential distribution of anionic sites

  1981cited by this paper
• Methods for Quantifying the transport of drugs across brain barrier systems.

  1981cited by this paper
• Receptor for albumin on the liver cell surface may mediate uptake of fatty acids and other albumin-bound substances.

  1981cited by this paper
• Glycoprotein molecular-weight estimation using sodium dodecyl sulfate-pore gradient electrophoresis: comparison of tris-glycine and tris-borate-EDTA buffer systems.

  1981cited by this paper
• Drug entry into the brain.

  1979cited by this paper
• Lower limits of cerebrovascular permeability to nonelectrolytes in the conscious rat.

  1978cited by this paper
• Short- and long-term effects of nerve growth factor on the sympathetic nervous system in the adult mouse.

  1975cited by this paper
• Selective accumulation of ( 125 I) labelled nerve growth factor in sympathetic ganglia.

  1972cited by this paper

• Translational Bayesian Pharmacokinetic Framework for Uncertainty-Aware First-in-Human Dose Selection of Therapeutic Monoclonal Antibodies

  2026influential citation
• Bridging the blood-brain barrier: strategies to improve delivery of biologics to tumors in the brain

  2026influential citation
• A Patient-Derived Antibody Ameliorates Disease Severity in a Relapsing Remitting Murine Model of Multiple Sclerosis.

  2026cites this paper
• Development of Positron Emission Tomography Radiotracers for Imaging α-Synuclein Aggregates

  2025influential citation
• Dual targeting of transferrin receptor and CD98hc enhances brain exposure of large molecules

  2025cites this paper
• Assessing central nervous system drug delivery

  2025cites this paper
• Elucidating molecular mechanisms governing tumor necrosis factor-alpha-mediated regulation of amyloid beta 42 uptake in blood-brain barrier endothelial cells.

  2025cites this paper
• Elucidating Molecular Mechanisms Governing TNF-Alpha-Mediated Regulation of Amyloid Beta 42 Uptake in Blood-Brain Barrier Endothelial Cells

  2025cites this paper
• Transferrin receptor-binding blood-brain barrier shuttle enhances brain delivery and plaque-clearing efficacy of a therapeutic anti-Aβ antibody

  2025influential citation
• Peripheral-nerve barrier and its implications for drug delivery.

  2025cites this paper
• Impact of diabetes on cellular connections: Pathological insights and emerging therapeutic targets.

  2025cites this paper
• Multiplex screening of transferrin receptor-targeted lipid nanoparticles for systemic brain delivery using DNA barcodes

  2025cites this paper
• Utilization of universal-targeting mSA2 CAR-T cells for the treatment of glioblastoma

  2025cites this paper
• Anti-tau VHH therapy against PHF6: a safe approach to slowing the phenotype of tau pathology

  2025influential citation
• A Site-Specific MiniAp4–Trastuzumab Conjugate Prevents Brain Metastasis

  2025cites this paper
• Structural insights into GPCR signaling activated by peptide ligands: from molecular mechanism to therapeutic application

  2025cites this paper
• [Blood-brain barrier breakdown and autoimmune cerebellar ataxia].

  2024cites this paper
• Engineered Antibodies to Improve Efficacy against Neurodegenerative Disorders

  2024cites this paper
• Metabolite transport across central nervous system barriers

  2024cites this paper
• Insulin Signaling Differentially Regulates the Trafficking of Insulin and Amyloid Beta Peptides at the Blood-Brain Barrier.

  2024cites this paper
• Paraneoplastic neuropathies and peripheral nerve hyperexcitability disorders.

  2024cites this paper
• Minimally invasive nasal infusion (MINI) approach for CNS delivery of protein therapeutics: A case study with ovalbumin.

  2024cites this paper
• Molecular Mechanisms Underlying Amyloid Beta Peptide Mediated Upregulation of Vascular Cell Adhesion Molecule-1 in Alzheimer Disease

  2024cites this paper
• Effective Nose-to-Brain Delivery of Blood-Brain Barrier Impermeant Anti-IL-1β Antibody via the Minimally Invasive Nasal Depot (MIND) Technique

  2024cites this paper
• Bioavailability as Proof to Authorize the Clinical Testing of Neurodegenerative Drugs—Protocols and Advice for the FDA to Meet the ALS Act Vision

  2024cites this paper
• Advances and Challenges in Gene Therapy for Alzheimer’s Disease

  2024cites this paper
• Small RNA Sequencing of Differentiated Astrocytoma exposed to NMOSD patient sera reveals perturbations in Neurodegenerative Signaling.

  2024cites this paper
• Selection of LRP1 ligand phage-displayed single domain antibody that transmigrates BBB

  2024influential citation
• The Evolving Applications of Bispecific Antibodies: Reaping the Harvest of Early Sowing and Planting New Seeds

  2024influential citation
• Delineating the effect of trehalose nanoparticles on aggregation pattern of apo-α-lactalbumin protein: A nano-approach towards counteracting proteinopathies

  2024cites this paper
• Evaluation of Tetrazine Tracers for Pretargeted Imaging within the Central Nervous System.

  2023cites this paper
• ImmunoPET Directed to the Brain: A New Tool for Preclinical and Clinical Neuroscience

  2023cites this paper
• Toxicologic Neuropathology of Novel Biotherapeutics

  2023cites this paper
• Perspectives on optimizing local delivery of drugs to peripheral nerves using mathematical models

  2023cites this paper
• Efficacy and Safety of Panitumumab in Patients With RAF/RAS-Wild-Type Glioblastoma: Results From the Drug Rediscovery Protocol

  2023cites this paper
• Serum immunoglobulin and the threshold of Fc receptor-mediated immune activation

  2023cites this paper
• GAP-43 targeted indocyanine green-loaded near-infrared fluorescent probe for real-time mapping of perineural invasion lesions in pancreatic cancer in vivo.

  2023cites this paper
• Drug Permeability: From the Blood–Brain Barrier to the Peripheral Nerve Barriers

  2023cites this paper
• Mechanisms of Obesity-Induced Changes in Pharmacokinetics of IgG in Rats

  2023cites this paper
• Bispecific antibody shuttles targeting CD98hc mediate efficient and long-lived brain delivery of IgGs

  2023cites this paper
• Uncovering CNS access of lipidated exendin-4 analogues by quantitative whole-brain 3D light sheet imaging.

  2023cites this paper
• Microglia and complement mediate early corticostriatal synapse loss and cognitive dysfunction in Huntington’s disease

  2023cites this paper
• CD98hc is a target for brain delivery of biotherapeutics

  2023influential citation
• Activation of protease-activated receptor-1 causes chronic pain in lupus-prone mice via suppressing spinal glial glutamate transporter function and enhancing glutamatergic synaptic activity.

  2023cites this paper
• Novel Human/Non-Human Primate Cross-Reactive Anti-Transferrin Receptor Nanobodies for Brain Delivery of Biologics

  2023cites this paper
• Research Strategy of Anti-Transferrin Receptor Antibody Targeting Intracerebral Drug Delivery

  2022cites this paper
• Evidence for cerebral microvascular injury in head trauma involving infants and young children

  2022cites this paper
• Alternative Routes of Administration for Therapeutic Antibodies—State of the Art

  2022cites this paper
• Breached Barriers: A Scoping Review of Blood-Central Nervous System Barrier Pathology in Amyotrophic Lateral Sclerosis

  2022cites this paper
• α‐Synuclein Radiotracer Development and In Vivo Imaging: Recent Advancements and New Perspectives

  2022cites this paper
• Research Strategy of Anti-Transferrin Receptor Antibody Targeting Intracerebral Drug Delivery

  2022cites this paper
• Typical and atypical properties of peripheral nerve allografts enable novel strategies to repair segmental-loss injuries

  2022cites this paper
• Aβ42 oligomer-specific antibody ALZ-201 reduces the neurotoxicity of Alzheimer’s disease brain extracts

  2022cites this paper
• Antibody-Based In Vivo Imaging of Central Nervous System Targets—Evaluation of a Pretargeting Approach Utilizing a TCO-Conjugated Brain Shuttle Antibody and Radiolabeled Tetrazines

  2022cites this paper
• Radiolabelling small and biomolecules for tracking and monitoring

  2022cites this paper
• Checkpoint: Inspecting the Barriers in Glioblastoma Immunotherapies.

  2022cites this paper
• The Immune System as a Therapeutic Target for Alzheimer’s Disease

  2022cites this paper
• Advancing 89Zr-immuno-PET in neuroscience with a bispecific anti-amyloid-beta monoclonal antibody - The choice of chelator is essential

  2022influential citation
• Engineering antibody and protein therapeutics to cross the blood–brain barrier

  2022influential citation
• Molecular architecture determines brain delivery of a transferrin receptor–targeted lysosomal enzyme

  2021cites this paper
• Nanoparticles as Artificial Chaperons Suppressing Protein Aggregation: Remedy in Neurodegenerative Diseases

  2021cites this paper
• Immune environment of the brain in schizophrenia and during the psychotic episode: A human post-mortem study

  2021influential citation
• Blood Supply and Microcirculation of the Peripheral Nerve

  2021cites this paper
• The Neurovascular Unit Dysfunction in Alzheimer’s Disease

  2021cites this paper
• Imaging and histopathologic features of reversible nerve root and peripheral nerve edema secondary to disc herniation in a cat

  2021cites this paper
• Microglia Mediate Early Corticostriatal Synapse Loss and Cognitive Dysfunction in Huntington’s Disease Through Complement-Dependent Mechanisms

  2021cites this paper
• Transport study of interleukin-1 inhibitors using a human in vitro model of the blood-brain barrier

  2021cites this paper
• Age-Dependent Changes in the Plasma and Brain Pharmacokinetics of Amyloid-β Peptides and Insulin

  2021cites this paper
• Therapeutic antibodies – natural and pathological barriers and strategies to overcome them

  2021cites this paper
• Nerve Growth Factor as an Ocular Therapy: Applications, Challenges, and Future Directions

  2021cites this paper
• Pretreatment with High Mobility Group Box-1 Monoclonal Antibody Prevents the Onset of Trigeminal Neuropathy in Mice with a Distal Infraorbital Nerve Chronic Constriction Injury

  2021cites this paper
• Applicability of cerebral open flow microperfusion and microdialysis to quantify a brain-penetrating nanobody in mice.

  2021cites this paper
• Pharmacophore-Based Design of Phenyl-[hydroxycyclohexyl] Cycloalkyl-Carboxamide Mitofusin Activators with Improved Neuronal Activity.

  2021cites this paper
• Systematic in silico analysis of clinically tested drugs for reducing amyloid‐beta plaque accumulation in Alzheimer's disease

  2021cites this paper
• Brain delivery of therapeutic proteins using an Fc fragment blood-brain barrier transport vehicle in mice and monkeys

  2020cites this paper
• Multispecific drugs herald a new era of biopharmaceutical innovation

  2020cites this paper
• HDL mimetic peptide 4F efficiently crosses the blood-brain barrier and modulates amyloid beta distribution between brain and plasma

  2020cites this paper
• Identification and in vivo characterization of a brain-penetrating nanobody

  2020cites this paper
• Biology of the human blood-nerve barrier in health and disease.

  2020influential citation
• Targeting Therapeutic Antibodies to the CNS: a Comparative Study of Intrathecal, Intravenous, and Subcutaneous Anti-Nogo A Antibody Treatment after Stroke in Rats

  2020cites this paper
• Interlink between insulin resistance and neurodegeneration with an update on current therapeutic approaches.

  2020cites this paper
• Effect of Peripheral Insulin Administration on Phosphorylation of Tau in the Brain

  2020cites this paper
• A TfR-Binding Cystine-Dense Peptide Promotes Blood-Brain Barrier Penetration of Bioactive Molecules.

  2020cites this paper
• A blood–brain barrier overview on structure, function, impairment, and biomarkers of integrity

  2020cites this paper
• The blood–brain barrier in health and disease: Important unanswered questions

  2020cites this paper
• New Insights into the Susceptibility of Immunocompetent Mice to Usutu Virus

  2020cites this paper
• Antibody screening using a human iPSC‐based blood‐brain barrier model identifies antibodies that accumulate in the CNS

  2020cites this paper
• Carbamazepine induces a bioenergetics disruption to microvascular endothelial cells from the blood-brain barrier.

  2020cites this paper
• Investigating the effect of sugar-terminated nanoparticles on amyloid fibrillogenesis of β-lactoglobulin.

  2020cites this paper
• Unexpected amount of blood-borne protein enters the young brain

  2020cites this paper
• Heparin-Hyaluronic Acid Nanofibers for Growth Factor Sequestration in Spinal Cord Repair.

  2020cites this paper
• High-Density Lipoprotein Mimetic Peptide 4F Efficiently Crosses the Blood-Brain Barrier and Modulates Amyloid-β Distribution between Brain and Plasma

  2020influential citation
• Involvement of Bradykinin Receptor 2 in Nerve Growth Factor Neuroprotective Activity

  2020cites this paper
• Brain metastasis models: What should we aim to achieve better treatments?

  2020cites this paper
• Progressive supranuclear palsy: Advances in diagnosis and management.

  2020cites this paper
• More Than Mortar: Glia as Architects of Nervous System Development and Disease

  2020cites this paper
• Vaccination against β-Amyloid as a Strategy for the Prevention of Alzheimer’s Disease

  2020cites this paper
• Blood–Nerve Barrier (BNB) Pathology in Diabetic Peripheral Neuropathy and In Vitro Human BNB Model

  2020influential citation
• Targeting the blood-nerve barrier for the management of immune-mediated peripheral neuropathies.

  2020cites this paper
• Brain Distribution of Drugs: Pharmacokinetic Considerations.

  2020cites this paper